MCG Health provides evidence-based clinical decision support guidelines and AI technology solutions to healthcare organisations across the United States. The company's core offering - evidence-based care guidelines - originated in 1988 from a collaboration between actuaries and physicians and has become widely adopted; over 3,200 hospitals and a majority of U.S. health plans use MCG's guidelines, which are also deployed by multiple government agencies.
MCG Health is part of Hearst Health, acquired by Hearst Corporation in November 2012. Within Hearst's healthcare division, the company operates alongside complementary platforms including Zynx Health and First Databank (FDB). The organisation's work centres on the intersection of actuarial science, clinical evidence, and risk assessment, helping healthcare providers and payers improve patient care outcomes whilst driving operational efficiency and cost containment.
The company's technical expertise spans clinical evidence synthesis, clinical decision support systems, actuarial science, risk-benefit calculations, data science, and utilisation management. This combination positions MCG Health as a provider of decision-support infrastructure for organisations navigating complex clinical and operational trade-offs within healthcare delivery and administration.
